General

About Company
Samus Therapeutics is developing novel therapeutics targeting the epichaperome.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2016

Number of employees

Company Type

For Profit

IPO status

Private

Description

Founded by Drs. Gabriela Chiosis and Larry Norton, Samus Therapeutics is focused on developing innovative treatments for cancer and neurological disorders, including Alzheimer's, Parkinson's, and chronic traumatic encephalopathy. Their lead programs, PU-H71 and PU-AD, are being evaluated in clinical studies for breast cancer, myelofibrosis, and Alzheimer's disease. Additionally, the company is advancing companion diagnostics programs to support their therapeutics.
Contacts

Phone number

Social url